Comparison 17. Honey products versus alternatives.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Complete healing at 12 weeks	2	476	Risk Ratio (M‐H, Fixed, 95% CI)	1.15 [0.96, 1.38]
2 Incidence of ulcer infection during the 12‐week trial period	2	476	Risk Ratio (M‐H, Fixed, 95% CI)	0.71 [0.49, 1.04]
3 Participants with MRSA eradication at 4 weeks	1	16	Risk Ratio (M‐H, Fixed, 95% CI)	4.2 [0.67, 26.30]
4 Participants reporting at least 1 adverse event	1	368	Risk Ratio (M‐H, Fixed, 95% CI)	1.28 [1.05, 1.56]